Brief: PetVivo Holdings Announces Release Of Clinical Study Results
31/01/2024 13:30
Jan 31 (Reuters) - PetVivo Holdings Inc PETV.O :
* PETVIVO HOLDINGS, INC. ANNOUNCES RELEASE OF CLINICAL STUDY
RESULTS INVOLVING CANINE TOLERANCE TO INTRA-ARTICULAR INJECTIONS
OF SPRYNG™ WITH OSTEOCUSHION™ TECHNOLOGY
Source text for Eikon: ID:nGNX9KXt8K
Further company coverage: PETV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PetVivo Holdings
See all newsBrief: Petvivo Holdings Inc On July 16, Raised $1.2 Mln Pursuant To Private Offering And Sale Of 3 Mln Units
Brief: PetVivo Holdings Terminates ATM Sales Agreement Between Co And ThinkEquity LLC
Brief: PetVivo Holdings Commences Trading On Upstream Under PETV
Newscasts - S&P 500, Nasdaq close at fresh records on AI boost
Advisory: Alert from FMW Media Work wrongly tagged to multiple companies withdrawn